We recently compiled a list of the 12 Best Japanese Stocks To Buy in 2025. In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the ...

Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical Industries, on Saturday dropped hints that the company could ...

In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Elite Pharmaceuticals ( ($ELTP) ) has released its Q3 earnings. Here is a breakdown of the information Elite Pharmaceuticals presented to its ...

Last year, Bristol Myers Squibb devoted half a page of its annual report to its diversity, equity and inclusion efforts, ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

Currrax Pharmaceuticals over-performed its 2024 revenue goal and has exceeded 50% year-over-year revenue growth for its ...

Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.